ALL (n = 775) | Validation cohorts (n = 233) | Training cohorts (n = 542) | P | |
---|---|---|---|---|
Group | 0.449 | |||
No-EGAL | 668 (86.2%) | 197 (84.5%) | 471 (86.9%) | |
EGAL | 107 (13.8%) | 36 (15.5%) | 71 (13.1%) | |
Sex (male), n (%) | 609 (78.6%) | 179 (76.8%) | 430 (79.3%) | 0.493 |
Age (years) | 62.0 [56.0; 67.0] | 63.0 [57.0; 67.0] | 62.0 [56.0; 67.0] | 0.522 |
Smoking history | 0.563 | |||
None | 336 (43.4%) | 106 (45.5%) | 230 (42.4%) | |
Moderate | 151 (19.5%) | 47 (20.2%) | 104 (19.2%) | |
Lots | 288 (37.2%) | 80 (34.3%) | 208 (38.4%) | |
BMI (kg/m2) | 21.9 [20.1; 23.8] | 22.0 [20.2; 23.9] | 21.7 [20.1; 23.7] | 0.277 |
Weight (kg) | 60.0 [53.5; 67.0] | 61.0 [54.5; 66.0] | 60.0 [53.0; 67.0] | 0.375 |
GNRI | 102 [97.9; 106] | 102 [98.1; 106] | 102 [97.9; 107] | 0.843 |
FEV1 (L) | 2.65 [2.16; 3.08] | 2.59 [2.18; 3.12] | 2.67 [2.14; 3.08] | 0.938 |
MVV (L) | 98.5 [82.7; 111] | 98.7 [83.3; 111] | 98.5 [82.7; 111] | 0.497 |
Alcohol consumption | 0.120 | |||
None | 531 (68.5%) | 162 (69.5%) | 369 (68.1%) | |
Moderate | 63 (8.13%) | 12 (5.15%) | 51 (9.41%) | |
Lots | 181 (23.4%) | 59 (25.3%) | 122 (22.5%) | |
Hypertension ( +), n (%) | 153 (19.7%) | 44 (18.9%) | 109 (20.1%) | 0.768 |
Diabetes ( +), n (%) | 64 (8.26%) | 17 (7.30%) | 47 (8.67%) | 0.620 |
CHD ( +), n (%) | 48 (6.19%) | 12 (5.15%) | 36 (6.64%) | 0.530 |
Neoadjuvant ( +), n (%) | 387 (49.9%) | 111 (47.6%) | 276 (50.9%) | 0.447 |
Location of tumor | 0.762 | |||
Upper | 57 (7.35%) | 16 (6.87%) | 41 (7.56%) | |
Middle | 364 (47.0%) | 106 (45.5%) | 258 (47.6%) | |
Lower | 354 (45.7%) | 111 (47.6%) | 243 (44.8%) | |
Position of anastomosis | 0.298 | |||
Neck | 741 (95.6%) | 226 (97.0%) | 515 (95.0%) | |
Intrathoracic | 34 (4.39%) | 7 (3.00%) | 27 (4.98%) | |
Duration of surgery (min) | 320 [288; 365] | 323 [289; 363] | 318 [288; 367] | 0.692 |
Blood loss (mL) | 97.3 [71.0; 123] | 94.5 [71.0; 121] | 98.4 [71.0; 123.3] | 0.200 |
Pathological staging | 0.975 | |||
0 | 59 (7.61%) | 18 (7.73%) | 41 (7.56%) | |
1 | 217 (28.0%) | 65 (27.9%) | 152 (28.0%) | |
2 | 208 (26.8%) | 66 (28.3%) | 142 (26.2%) | |
3 | 267 (34.5%) | 77 (33.0%) | 190 (35.1%) | |
4 | 24 (3.10%) | 7 (3.00%) | 17 (3.14%) | |
Number of lymph node dissection | 33.0 [25.0; 42.0] | 32.0 [26.0; 42.0] | 33.0 [25.0; 42.0] | 0.999 |
Vascular invasion ( +), n (%) | 153 (19.8%) | 44 (18.9%) | 109 (20.1%) | 0.759 |
Nerve infiltration ( +), n (%) | 217 (28.0%) | 64 (27.5%) | 154 (28.4%) | 0.788 |
Hospitalization days (day) | 10.0 [8.00; 14.0] | 10.0 [8.00; 14.0] | 11.0 [8.00; 14.0] | 0.205 |
Neck extubation (day) | 6.00 [4.00; 8.00] | 6.00 [4.00; 8.00] | 6.00 [4.00; 8.00] | 0.143 |
Surgical methods | 0.832 | |||
Thoracoscope | 635 (81.9%) | 191 (82.0%) | 444 (81.9%) | |
DVSS | 140 (18.1%) | 42 (18.0%) | 98 (18.1%) |